top of page

Search Results

Results found for "preclinical pharmacology"

  • 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024

    We’ve made some updates to the Principles of Pharmacology I & II courses, and we can’t wait for you Here’s the refreshed schedule: Principles of Pharmacology I October 3, 10, 17, 24 Principles of Pharmacology Don’t miss out on insightful resources like '   Applying Pharmacology to Drug Discovery ' and ' Advanced Data Analysis for GPCR Pharmacology .' Don’t miss your chance to dive into the Principles of Pharmacology I & II BUNDLE .

  • Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox

    For decades, GPCRs have been the cornerstone of pharmacology. Projects in his group often begin with either: A new GPCR structure  ripe for exploration, or A pharmacological Carlsson’s group integrates modeling with mechanistic pharmacology. improved GPCR structures, and scalable experimental assays is shrinking the gap between modeling and pharmacology Forward The Carlsson lab exemplifies how c omputational biochemistry can meaningfully impact real-world pharmacology

  • Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...

    April 2022 Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders Addex Therapeutics "Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the pharmacology

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    Career opportunities:  Principal Scientist - In Vitro Pharmacology; Senior Scientist, Molecular Pharmacology Weekly News : jobs, events, papers, industry updates Exclusive discounts on Terry’s Corner  digital pharmacology access to insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who Edition here ➤    Access all the news and upcoming events Hashtags: #GPCR #DrGPCR #BindingAffinity #Pharmacology

  • Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells

    Pharmacology & Therapeutics   2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007 European Journal of Pharmacology   2017 , 799 , 58–66. https://doi.org/10.1016/j.ejphar.2017.01.040 . European Journal of Pharmacology   2018 , 839 , 40–46. https://doi.org/10.1016/j.ejphar.2018.09.008 . Trends in Pharmacological Sciences   2018 , 39  (2), 187–199. https://doi.org/10.1016/j.tips.2017.10.004 Biochemical Pharmacology   1973 , 22 (23), 3099–3108. https://doi.org/10.1016/0006-2952(73)90196-2 .

  • What If Your Data is Lying to You? The Calcium Assay Dilemma

    Because when true pharmacological profiling is essential—like detecting partial or inverse agonism—calcium If you're starting out in pharmacology, this lesson gives you the interpretive tools to ask smarter questions calcium assays with strategic clarity. 📍 Foundational Level | Calcium Assays 📚 Part of Terry Kenakin’s Pharmacology

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    GPCR Enthusiasts , Get ready for an exciting learning experience with our newly updated Principles of Pharmacology New Course Dates: Principles of Pharmacology I :  October 3, 10, 17, 24 (four sessions) Principles of Pharmacology II :  October 31, November 7, 14, 21, December 5 (five sessions) Courses Highlights Act Fast: Don’t miss this incredible opportunity to immerse yourself in the  Principles of Pharmacology and ' Advanced Data Analysis for GPCR Pharmacology' ."

  • Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs

    They stall when chemistry, modeling, and pharmacology drift apart. These sessions span foundational pharmacology, receptor biology, modeling, translational strategy, and Premium Members also receive a 50%+ discount on Terry’s Corner — unlocking advanced pharmacology depth

  • Conjugation Strategies for Probe Development

    Hello Dr.GPCR readers! This is Lucía from the Celtarys Research chemistry team.  For our very first post in this ecosystem, we wanted to highlight a huge part of our work at Celtarys Research: conjugation strategies. You can check what we do here on our website!   Conjugation strategies for small molecules are very versatile! In this case, we would like to focus on the synthesis of fluorescent probes. Traditionally, the most reliable and commonly used method is the amide coupling  using acid and amine .[ 1 ] This method has several advantages: it is usually very robust, good yields, reagents are found in most chem labs (like HATU, HoBT, EDCI etc.). Still, there are some downsides, such as the byproduct obtained by the O-acylisourea rearranging intramolecularly into the N-acylurea.[ 2]     NHS ester amide coupling  is the most suited for bioconjugation with proteins, DNA, etc, thanks to its reaction with the free amino groups present in these biomolecules. NHS esters are not very stable even in aqueous environment but they only need a slightly basic medium for the reaction to work, so they have to be used quickly and stored correctly. Not only do they work in aqueous medium, but also in aprotic solvents like DMF, where you will need to add a base such as TEA. [ 3]     Maleimide  conjugation with thiols  present Cys residues. This conjugation is very useful for tagging biomolecules and can also be used to develop fluorescent probes with small molecules. Its biggest advantage is the presence of Cys residues in proteins, although sometimes S-S bridge reduction is needed, and how quickly the reaction takes place. The biggest detractor? It’s reversible under non-reducing conditions. [ 4]     Other strategies include click chemistry,  more specifically, the CuAAC (Cu(I)- catalyzed azide-alkyne 1,3-dipolar cycloaddition), which is a very robust conjugation strategy to obtain linkers with a rigid moiety (the triazol). But it also presents some issues, such as synthesizing the as the presence of the copper catalyst, which has to be removed completely, otherwise it can quelate biomolecules or induce cell toxicity. [ 5]     At Celtarys’ we have our conjugation strategy - our own proprietary technology- which bypasses some of the issues seen before. There’s no need for any catalysts; all reagents will be incorporated in the structure of the final compound. The reaction is convergent, efficient and robust. Thanks to the unique linker structure we obtain, which can be divided into three differentiated parts, we can modify the rigidity of the linker as well as the physicochemical properties of the whole probe. This property comes from the wide chemical space this reaction can access – we can substitute one reagent and make an unprecedented combination, also using commercially available precursor, which improves the performance of the probes.  It also poses some disadvantages – just like acid-amine amide coupling, some byproducts are obtained during the synthesis. However, these are usually easily removable. Besides, it’s an eco-friendlier method, which always helps future-proof our probes!  References   (1) Brown, D. G.; Boström, J. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?: Miniperspective. J. Med. Chem.   2016 , 59  (10), 4443–4458. https://doi.org/10.1021/acs.jmedchem.5b01409 .   (2) Sam, S.; Touahir, L.; Salvador Andresa, J.; Allongue, P.; Chazalviel, J.-N.; Gouget-Laemmel, A. C.; Henry De Villeneuve, C.; Moraillon, A.; Ozanam, F.; Gabouze, N.; Djebbar, S. Semiquantitative Study of the EDC/NHS Activation of Acid Terminal Groups at Modified Porous Silicon Surfaces. Langmuir   2010 , 26  (2), 809–814. https://doi.org/10.1021/la902220a .   (3) Fan, J.; Toth, I.; Stephenson, R. J. Chapter Three - Bioconjugated Materials in the Development of Subunit Vaccines. In Comprehensive Analytical Chemistry ; Verma, S. K., Das, A. K., Eds.; Elsevier, 2023; Vol. 103, pp 59–103. https://doi.org/10.1016/bs.coac.2023.02.005 .   (4) Fontaine, S. D.; Reid, R.; Robinson, L.; Ashley, G. W.; Santi, D. V. Long-Term Stabilization of Maleimide–Thiol Conjugates. Bioconjugate Chem.   2015 , 26  (1), 145–152. https://doi.org/10.1021/bc5005262 .   (5) Meldal, M.; Tornøe, C. W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem. Rev.   2008 , 108  (8), 2952–3015. https://doi.org/10.1021/cr0783479 .

  • Purpose-Driven Opioid Research: Catherine Demery’s Academic Path

    Rather than treating opioid pharmacology as a purely theoretical exercise, she collaborates with harm-reduction This approach makes her models not just rigorous, but translational—bridging the gap between receptor pharmacology That personal loss transforms complex receptor pharmacology into something immediate and human. Real-world data should guide how we build preclinical models. And GPCR pharmacology isn’t just an academic pursuit—it’s essential to understanding and responding to

  • Combined docking and machine learning identify key molecular determinants of ligand pharmacological

    detailed structure‐activity relationship that identifies small changes to the ligands that invert their pharmacological

  • Better GPCR Drug Discovery Decisions Start With Structured Learning

    It is operational pharmacology designed to prevent avoidable setbacks. Premium Members also receive a 50%+ discount on Terry’s Corner , unlocking advanced pharmacology depth

  • Fentanyl and Xylazine: Why Breathing Fails in Overdose

    First responders describe revivals that don’t feel like revivals, as if the body is still trapped in a pharmacological Catherine’s work lays the foundation for designing better interventions, from preclinical models to clinical

  • From GPCR Data Chaos to Decisive Action

    Consulting Philosophy Every successful GPCR program is a blend of scientific excellence  and operational precision

  • Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026

    Career opportunities:  In vitro Pharmacology Research Assistant—Geneva. Why this matters now: PK defines translatability  — activity without exposure is not pharmacology. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions

    exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted for pharmacologists Exploit probe dependence to shape precision pharmacology.  Want to avoid off-target effects? If you work on GPCRs across translational pharmacology, drug development, or molecular pharmacology, GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

  • Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success

    Every R&D team is under the same pressure: deliver validated targets, clean pharmacology, and translatable Allosteric Interactions Still Matter Orthosteric and allosteric interactions have been in pharmacology learn why this distinction is not just theory, but a practical framework to design cleaner, smarter pharmacology Equip your team with this literacy now to design cleaner pharmacology and accelerate smarter, safer programs lectures  that sharpen the tools you actually use in discovery A growing on-demand library  of expert pharmacology

  • Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...

    December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological ASCEPT is the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology Established in 1966, ASCEPT is affiliated with the International Union of Basic and Clinical Pharmacology

  • Understanding the Journey: Catherine Demery's Path to Addiction Science

    It’s rigorous pharmacology, but deeply tied to urgent public health needs.

  • Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...

    August 2022 Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, We now summarize important pharmacological, molecular, and cellular studies relevant to D1-mediated β-arrestin-related discuss the importance of understanding the translatability of cell and animal models to have more precise

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • Why Opposing Processes Matter for Your Next GPCR Drug

    This section outlines the logic required to match preclinical models to patient physiology and avoid β-receptor partial agonists, showing how heart rate set-points under different anesthetics can flip observed pharmacology Subscribe today and get direct access to decades of pharmacology experience that turn complex systems Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots.

  • A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...

    August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology monitor the activation state of G protein-coupled receptors are a useful addition to the molecular pharmacology

  • Quantifying Receptor Selectivity in Modern Drug Discovery

    discovery teams from advancing compounds based on artifacts of expression systems rather than intrinsic pharmacology If the assay threshold is too high, real pharmacology becomes invisible. Whole-Cell Responses: A Historical Complication Historically, pharmacology relied on whole-cell or tissue Strategic Implications for Drug Hunters Quantifying receptor selectivity correctly does more than refine pharmacological Why Terry’s Corner Terry’s Pharmacology Corner delivers weekly lectures from Dr.

  • Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research

    Twist Bioscience's technology addresses inefficiencies and enables cost-effective, rapid, precise, high-throughput British J Pharmacology 2007 , 152 (4), 429–448. https://doi.org/10.1038/sj.bjp.0707332 . (4) Barbazán Pharmacological Research 2021 , 174 , 105970. https://doi.org/10.1016/j.phrs.2021.105970 . (6) Miranda-Pastoriza

  • Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism

    Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair. Schild analysis turns receptor pharmacology into detective work, spotlighting mechanistic fingerprints Modern pharmacology has powerful modeling software, yet Schild analysis remains the litmus test for mechanism Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr. Built for pharmacologists refining tools, discovery teams solving bottlenecks, and leaders seeking credible

  • Breaking the Myth of High and Low Affinity Sites

    Yet some assumptions still shaping pharmacology workflows haven’t evolved as fast as today’s science. Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology

  • GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors

    Corner , our founder Yamina Berchiche works closely with organizations to help them navigate receptor pharmacology Push the boundaries  of receptor pharmacology and its real-world applications.   📚 Terry’s Corner — The Only On-Demand Pharmacology Hub with Dr. GPCR  community, you already know about Terry’s Corner  — our exclusive, on-demand pharmacology series where Terry Kenakin breaks down receptor pharmacology, functional selectivity, and ligand bias in a

  • From Pipettes to Platforms: The Evolution of GPCR Research

    Every step felt like it could make or break the result, The pace and precision of GPCR research today Today, success depends less on manual precision and more on experimental design, data interpretation, What started as hand-built assays on ice has become integrated platforms for drug discovery, systems pharmacology

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    Rethinking Affinity, A Critical Edge for Drug Hunters One of the most persistent misconceptions in pharmacology apparent affinity differences delays key milestones. 🗣️ “Thank you for bringing this (Principles of Pharmacology At Alkermes, Sokhom Pin built an in vitro pharmacology group from scratch—not just a lab, but a culture Weekly News : jobs, events, papers, industry updates Exclusive discounts on Terry’s Corner  digital pharmacology Access this week’s full Premium Edition here ➤ Hashtags: #GPCR #DrGPCR #BindingAffinity #Pharmacology

bottom of page